The Journal of Arthroplasty
Volume 27, Issue 2 , Pages 167-172, February 2012

Pulmonary Embolism Prophylaxis in More Than 30,000 Total Knee Arthroplasty Patients: Is There a Best Choice?

  • Monti Khatod, MD

      Affiliations

    • Department of Orthopaedic Surgery, Southern California Permanente Medical Group, Baldwin Park, California
    • Corresponding Author InformationReprint requests: Monti Khatod, MD, Department of Orthopaedic Surgery, Kaiser Permanente Baldwin Park, 1011 Baldwin Park Blvd. Baldwin Park, CA 91706.
  • ,
  • Maria C.S. Inacio, MS

      Affiliations

    • Department of Surgical Outcomes and Analysis, Southern California Permanente Medical Group, San Diego, California
  • ,
  • Stefano A. Bini, MD

      Affiliations

    • Department of Orthopaedic Surgery, The Permanente Medical Group, Oakland, California
  • ,
  • Elizabeth W. Paxton, MA

      Affiliations

    • Department of Surgical Outcomes and Analysis, Southern California Permanente Medical Group, San Diego, California

Received 19 January 2011; accepted 2 April 2011. published online 06 June 2011.

Abstract 

Prophylaxis for pulmonary embolism (PE) prevention in total knee arthroplasty remains controversial. A joint registry evaluated venous thromboembolism prophylaxis and anesthesia impact on the incidence of PE, fatal PE, and death. Patients received mechanical prophylaxis alone or chemical with or without mechanical prophylaxis. The overall PE incidence was 0.45%; fatal PE, 0.01%; and death, 0.31%. The only significant difference in any outcome was the incidence of PE between Coumadin and mechanical prophylaxis alone. Variables associated with a higher incidence of PE were age, an American Society of Anesthesiologists score of 3 or higher, and the use of general anesthesia. Based on the findings, general anesthesia can be discouraged, and only Coumadin fared better than mechanical prophylaxis alone, whereas other forms of chemical prophylaxis revealed no significant differences.

Keywords: knee arthroplasty, pulmonary embolism, prophylaxis, registry

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Source of funding: There was no external funding source.

 The Conflict of Interest statement associated with this article can be found at doi:10.1016/j.arth.2011.04.006.

PII: S0883-5403(11)00164-1

doi:10.1016/j.arth.2011.04.006

The Journal of Arthroplasty
Volume 27, Issue 2 , Pages 167-172, February 2012